Stuka Paul 4
4 · InspireMD, Inc. · Filed May 8, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Paul Stuka Buys 7,895 Shares
What Happened Paul Stuka, a director of InspireMD, acquired a total of 7,895 shares in two open-market purchases: 1,517 shares on 2026-05-06 at $1.12 per share (cost $1,699) and 6,378 shares on 2026-05-07 at an average price of $1.15 per share (cost $7,335). The combined outlay was $9,034. These were purchases (transaction code P), which investors often view as a more positive signal than sales, though filings do not state motivation.
Key Details
- Transaction dates and prices:
- 2026-05-06: 1,517 shares @ $1.12 ($1,699)
- 2026-05-07: 6,378 shares @ $1.15 (weighted average) ($7,335)
- Total shares acquired: 7,895; total value: $9,034.
- Shares owned after the transactions: Not specified in the filing.
- Footnote: The $1.15 price is a weighted average; the May 7 block was purchased in multiple trades at prices ranging from $1.14 to $1.15. The reporting person can provide a breakdown on request.
- Remarks/Exhibits: Exhibit 24.1 (Power of Attorney) attached.
- Filing timeliness: Form 4 was filed on 2026-05-08 covering trades on May 6–7; this appears timely under the two-business-day reporting rule.
Context
- Code P indicates a direct purchase of shares. Purchases by insiders can be interpreted as a vote of confidence, but the monetary size here (~$9k) is modest; small buys can be routine and may not indicate a major change in outlook.
- The filing does not indicate 10% owner status or the use of a 10b5-1 plan.
Insider Transaction Report
Form 4
InspireMD, Inc.NSPR
Stuka Paul
Director
Transactions
- Purchase
Common Stock
2026-05-06$1.12/sh+1,517$1,699→ 525,221 total - Purchase
Common Stock
[F1]2026-05-07$1.15/sh+6,378$7,335→ 531,599 total
Footnotes (1)
- [F1]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.14 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Signature
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka|2026-05-08